Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum

Journal of Neurochemistry

Volumn 86, Issue 2, 2003, Pages 451-459

  Pozzi, Laura ^a,c   Håkansson, Kerstin ^a   Usiello, Alessandro ^a   Borgkvist, Anders ^a   Lindskog, Maria ^a   Greengard, Paul ^b   Fisone, Gilberto ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Clozapine; DARPP 32; Dopamine D2 receptors; Eticlopride; Haloperidol; Mitogen activated protein kinases

Indexed keywords

CLOZAPINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROLEPTIC AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG PROTEIN BINDING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; ETS-DOMAIN PROTEIN ELK-1; HALOPERIDOL; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; SALICYLAMIDES; TRANSCRIPTION FACTORS;

ANIMALIA; CERVUS ELAPHUS;

EID: 0038155088     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01851.x     Document Type: Article

References (40)

1. Brunello N., Masotto C., Steardo L., Markstein R. and Racagni G. (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13, 177-213.
2. 2 dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J. Neurosci. 20, 1849-1857.
3. Choe E. S. and McGinty J. F. (2001) Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum. J. Neurochem. 76, 401-412.
4. Deutsch A. Y., Lee M. C. and Iadarola M. J. (1992) Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Mol. Cell Neurosci. 3, 332-341.
5. Dragunow M., Robertson G. S., Faull R. L. M., Robertson H. A. and Janssen K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37, 287-294.
6. Gerfen C. R., Miyachi S., Paletzky R. and Brown P. (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054.
7. Gille H., Kortenjamm M., Thomae O., Moomaw C., Slaughter C., Cobb M. H. and Shaw P. E. (1995) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14, 951-962.
8. Gonzales G. A. and Montminy M. R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
9. Grewal S. S., York R. D. and Stork P. J. S. (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin. Neurobiol. 9, 544-553.
10. Guo N., Klitenick M. A., Tham C. S. and Fibiger H. C. (1995) Receptor mechanism mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65, 747-756.
11. Hemmings H. C. J. and Greengard P. (1986) DARPP-32, a dopamine-and adenosine 3′: 5′-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J. Neurosci. 6, 1469-1481.
12. Hemmings J. H. C., Greengard P., Tung H. Y. L. and Cohen P. (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505.
13. Hipskind R. A., Rao V. N., Mueller C. G. F., Reddy E. S. P. and Nordheim A. (1991) Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354, 531-534.
14. Hipskind R. A., Baccarini M. and Nordheim A. (1994) Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell Biol. 14, 6219-6231.
15. Konradi C. and Heckers S. (1995) Haloperidol-induced fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Neuroscience 65, 1051-1061.
16. Konradi C., Kobierski L. A., Nguyen T. V., Heckers S. and Hyman S. E. (1993) The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc. Natl Acad. Sci. USA 90, 7005-7009.
17. Leveque J.-C., Macias W., Rajadhyaksha A., Carlson R. R., Barczak A., Kang S., Li X.-M., Coyle J. T., Huganir R. L., Heckers S. and Konradi C. (2000) Intracellular modulation of NMDA receptors function by antipsychotic drugs. J. Neurosci. 20, 4011-4020.
18. MacGibbon G. A., Lawlor P. A., Bravo R. and Dragunow M. (1994) Clozapine and haloperidol produce a differential pattern of immediate gene expression in the rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol. Brain Res. 23, 21-32.
19. Marais R., Wynne J. and Treisman R. (1993) The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73, 381-393.
20. i values. J. Pharmac. Exp. Ther 251, 238-246.
21. Miller J. C. (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54, 1453-1455.
22. Nguyen T. V., Kosofsky B. E., Birnbaum R., Cohen B. M. and Hyman S. E. (1992) Differential expresion of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl Acad. Sci. USA 89, 4270-4274.
23. Nishi A., Snyder G. L. and Greengard P. (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147-8155.
24. Park T.-J., Bae S.-I., Choi S.-Y., Kang B.-J. and Kim K.-T. (2001) Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells. Biochem. Pharmacol. 61, 1011-1019.
25. Pisa M. and Schranz J. A. (1988) Dissociable motor roles of the rat's striatum conform to a somatotopic model. Behav. Neurosci. 102, 429-440.
26. 2+ channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19, 6348-6359.
27. Robertson G. S. and Fibiger H. C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46, 315-328.
28. Selcher J. C., Atkins C. M., Trzaskos J. M., Paylor R. and Sweatt J. D. (1999) A necessity for MAP kinase activation in mammalian spatial learning. Learn. Mem. 6, 478-490.
29. Sgambato V., Pagès C., Rogard M., Besson M.-J. and Caboche J. (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814-8825.
30. (2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427-1430.
31. Snyder G. L., Girault J.-A., Chen J., Czemik A. J., Kebabian J. W., Nathanson J. A. and Greengard P. (1992) Phosphorylation of DARPP-32 and inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J. Neurosci. 12, 3071-3083.
32. Stoof J. C. and Kebabian J. W. (1981) Opposing roles for D-1 and D-2 dopamine rceptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368.
33. Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B. and Fisone G. (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl Acad. Sci. USA 97, 1856-1860.
34. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. NatlAcad. Sci. USA 76, 4350-4354.
35. Treisman R. (1995) Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14, 4905-4913.
36. Vanhoutte P., Barnier J.-V., Guibert B., Pagès C., Besson M.-J., Hipskind R. A. and Caboche J. (1999) Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell Biol. 19, 136-146.
37. Walaas S. I., Aswad D. W. and Greengard P. (1983) DARPP-32, a dopamine- and cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71.
38. Xing J., Ginty D. D. and Greenberg M. E. (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273, 959-963.
39. 2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element binding protein phosphorylation in neurons. Proc. Natl Acad. Sci. USA 96, 11607-11612.
40. Young C. D., Bubser M., Meltzer H. Y. and Deutch A. Y. (1999) Clozapine pretreatment modifies haloperidol-elicited forebrain induction: a regionally-specific double dissociation. Psychopharmacology 144, 255-263.